Sangamo Therapeutics
SGMO
SGMO
182 hedge funds and large institutions have $315M invested in Sangamo Therapeutics in 2022 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 63 increasing their positions, 60 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
34% less capital invested
Capital invested by funds: $477M → $315M (-$162M)
43% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 30
Holders
182
Holding in Top 10
–
Calls
$1.18M
Puts
$639K
Top Buyers
| 1 | +$8.86M | |
| 2 | +$4.13M | |
| 3 | +$3.44M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$3.07M |
| 5 |
LFCM
Long Focus Capital Management
San Juan,
Puerto Rico
|
+$1.7M |
Top Sellers
| 1 | -$2.06M | |
| 2 | -$2.05M | |
| 3 | -$1.48M | |
| 4 |
Millennium Management
New York
|
-$1.3M |
| 5 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$1.07M |